Amarin Corp Plc (AMRN)

[ggwpq]

Zum, thanks for the article. Clearly written by PCSK9 promoters. Several observations,

1) p.5 show statins' RRR is in the teens. I bet V has better standalone RRR.

2) Surprised that statins are more efficacious for patients with no known history of CVD, probably cooking the data on the part of PCSK9 promoters.

3) 5.4% annual event rate for patients with history of CVD is in the ball park of sicker R-IT patients' estimate.

4) Why Northern Europe has so much FH? (p.15)

5) To dis-credit hypertrig., it quotes a 1991 paper (p.14).

http://www.ncbi.nlm.nih.gov/pubmed/1888927